Telmisartan w badaniach klinicznych Omówienie
##plugins.themes.bootstrap3.article.main##
Abstrakt
Brak
##plugins.themes.bootstrap3.article.details##
Jak cytować
Lewandowski , J. (2013). Telmisartan w badaniach klinicznych . Medycyna Faktów , 6(2(19), 79-84. Pobrano z https://journalsmededu.pl/index.php/jebm/article/view/2419
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Inoue T., Morooka T., Moroe K., Ikeda H., Node K.: Effect of telmisartan on cholesterol levels in patients with hypertension – Saga Telmisartan Aggressive Research (STAR). Horm. Metab. Res. 2007; 39(5): 372-376.
2. Parati G., Bilo G., Redon J. w imieniu komitetu koordynującego badanie SURGE: The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2). Hypertension Research 2012 [online: doi: 10.1038/hr.2012.171].
3. Vitale C., Mercuro G., Castiglioni C., Cornoldi A., Tulli A., Fini M., Volterrani M., Rosano G.: Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome. Cardiovascular Diabetology 2005; 4: 6.
2. Parati G., Bilo G., Redon J. w imieniu komitetu koordynującego badanie SURGE: The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2). Hypertension Research 2012 [online: doi: 10.1038/hr.2012.171].
3. Vitale C., Mercuro G., Castiglioni C., Cornoldi A., Tulli A., Fini M., Volterrani M., Rosano G.: Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome. Cardiovascular Diabetology 2005; 4: 6.